|
2026-05-11 |
2026-05-08 |
B
Purchase
|
Non-Executive Director
|
33,664
+50.0%
214.69
US$3,742,053
|
33,664
+50.0%
|
214.69
|
US$3,742,053
|
|
|
2026-05-05 |
2026-05-01 |
B
Purchase
|
Non-Executive Director
|
46,103
+33.4%
359.76
US$2,414,714
|
46,103
+33.4%
|
359.76
|
US$2,414,714
|
|
|
2026-03-11 |
2026-03-10 |
B
Purchase
|
Non-Executive Director
|
72,132
-29.1%
202.37
US$1,689,705
|
72,132
-29.1%
|
202.37
|
US$1,689,705
|
|
|
2026-02-23 |
2026-02-19 |
B
Purchase
|
Non-Executive Director
|
50,000
+inf%
9.16
US$458,000
|
50,000
+inf%
|
9.16
|
US$458,000
|
|
|
2026-02-12 |
2026-02-12 |
B
Purchase
|
Non-Executive Director
|
100,000
+33.3%
9.40
US$940,000
|
100,000
+33.3%
|
9.40
|
US$940,000
|
|
|
2025-12-09 |
2025-12-05 |
B
Purchase
|
Non-Executive Director
|
350,000
+inf%
11.09
US$3,881,500
|
350,000
+inf%
|
11.09
|
US$3,881,500
|
|
|
2025-11-17 |
2025-11-17 |
B
Purchase
|
President and CEO
Executive Director
|
87,500
+44.7%
11.35
US$993,125
|
87,500
+44.7%
|
11.35
|
US$993,125
|
|
|
2025-11-06 |
2025-11-06 |
PrS
Proposed sale
|
officer
Officer
|
29,131
25.16
US$732,926
|
29,131
|
25.16
|
US$732,926
|
|
|
2025-10-31 |
2025-10-30 |
B
Purchase
|
Non-Executive Director
|
100,000
+50.0%
11.25
US$1,125,000
|
100,000
+50.0%
|
11.25
|
US$1,125,000
|
|
|
2025-08-22 |
2025-08-21 |
B
Purchase
|
Non-Executive Director
|
100,000
+100.0%
12.56
US$1,256,000
|
100,000
+100.0%
|
12.56
|
US$1,256,000
|
|
|
2025-08-06 |
2025-08-05 |
S
Sale
|
SVP & Chief Accounting Officer
Officer
|
3,476
-5.9%
11.39
US$39,592
|
3,476
-5.9%
|
11.39
|
US$39,592
|
|
|
2025-08-05 |
2025-08-05 |
PrS
Proposed sale
|
Officer
Officer
|
3,476
11.39
US$39,592
|
3,476
|
11.39
|
US$39,592
|
|
|
2025-05-27 |
2025-05-23 |
B
Purchase
|
Non-Executive Director
|
30,000
+42.9%
12.50
US$375,000
|
30,000
+42.9%
|
12.50
|
US$375,000
|
|
|
2025-05-22 |
2025-05-22 |
B
Purchase
|
Non-Executive Director
|
20,000
+40.0%
12.65
US$253,000
|
20,000
+40.0%
|
12.65
|
US$253,000
|
|
|
2025-05-09 |
2025-05-07 |
B
Purchase
|
Non-Executive Director
|
25,000
+100.0%
12.00
US$300,000
|
25,000
+100.0%
|
12.00
|
US$300,000
|
|
|
2025-04-29 |
2025-04-29 |
B
Purchase
|
Non-Executive Director
|
8,100
+30.1%
12.30
US$99,630
|
8,100
+30.1%
|
12.30
|
US$99,630
|
|
|
2025-04-29 |
2025-04-28 |
B
Purchase
|
Non-Executive Director
|
5,000
+16.5%
12.57
US$62,850
|
5,000
+16.5%
|
12.57
|
US$62,850
|
|
|
2025-04-29 |
2025-04-28 |
B
Purchase
|
Non-Executive Director
|
25,000
+inf%
12.50
US$312,500
|
25,000
+inf%
|
12.50
|
US$312,500
|
|
|
2025-04-29 |
2025-04-28 |
B
Purchase
|
Non-Executive Director
|
8,091
+4.2%
12.81
US$103,646
|
8,091
+4.2%
|
12.81
|
US$103,646
|
|
|
2025-02-28 |
2025-02-27 |
S
Sale
|
EVP Sales, Customer Excellence
Officer
|
774
-0.9%
17.00
US$13,158
|
774
-0.9%
|
17.00
|
US$13,158
|
|
|
2025-02-28 |
2025-02-27 |
S
Sale
|
SVP & Chief Accounting Officer
Officer
|
1,033
-2.5%
17.00
US$17,561
|
1,033
-2.5%
|
17.00
|
US$17,561
|
|
|
2025-02-27 |
2025-02-27 |
PrS
Proposed sale
|
Officer
Officer
|
774
17.01
US$13,165
|
774
|
17.01
|
US$13,165
|
|
|
2025-02-27 |
2025-02-27 |
PrS
Proposed sale
|
Officer
Officer
|
1,033
17.01
US$17,571
|
1,033
|
17.01
|
US$17,571
|
|
|
2025-02-28 |
2025-02-26 |
S
Sale
|
EVP Sales, Customer Excellence
Officer
|
3,758
-4.1%
17.53
US$65,878
|
3,758
-4.1%
|
17.53
|
US$65,878
|
|
|
2025-02-28 |
2025-02-26 |
S
Sale
|
SVP & Chief Accounting Officer
Officer
|
4,907
-10.8%
17.53
US$86,020
|
4,907
-10.8%
|
17.53
|
US$86,020
|
|
|
2025-02-26 |
2025-02-26 |
PrS
Proposed sale
|
Officer
Officer
|
3,758
17.53
US$65,893
|
3,758
|
17.53
|
US$65,893
|
|
|
2025-02-26 |
2025-02-26 |
PrS
Proposed sale
|
Officer
Officer
|
4,907
17.53
US$86,040
|
4,907
|
17.53
|
US$86,040
|
|
|
2024-09-06 |
2024-09-05 |
S
Sale
|
SVP & Chief Accounting Officer
Officer
|
3,525
-10.7%
25.06
US$88,336
|
3,525
-10.7%
|
25.06
|
US$88,336
|
|
|
2024-09-05 |
2024-09-05 |
PrS
Proposed sale
|
Officer
Officer
|
3,525
25.06
US$88,336
|
3,525
|
25.06
|
US$88,336
|
|
|
2024-08-26 |
2024-08-26 |
PrS
Proposed sale
|
Officer
Officer
|
17,000
25.54
US$434,246
|
17,000
|
25.54
|
US$434,246
|
|
|
2024-08-01 |
2024-07-31 |
S
Sale
|
EVP, AMEA
Officer
|
100
-0.1%
28.00
US$2,800
|
100
-0.1%
|
28.00
|
US$2,800
|
|
|
2024-07-31 |
2024-07-31 |
PrS
Proposed sale
|
Officer
Officer
|
100
28.00
US$2,800
|
100
|
28.00
|
US$2,800
|
|
|
2024-08-01 |
2024-07-30 |
PlS
Planned sale
|
EVP, AMEA
Officer
|
10,000
-11.9%
27.00
US$270,000
|
10,000
-11.9%
|
27.00
|
US$270,000
|
|
|
2024-07-30 |
2024-07-30 |
PrS
Proposed sale
|
Officer
Officer
|
10,000
27.01
US$270,061
|
10,000
|
27.01
|
US$270,061
|
|
|
2024-07-26 |
2024-07-26 |
PrS
Proposed sale
|
Former officer
Officer
|
143,523
22.84
US$3,278,348
|
143,523
|
22.84
|
US$3,278,348
|
|
|
2024-03-12 |
2024-03-08 |
PrS
Proposed sale
|
Officer
Officer
|
3,685
25.78
US$95,000
|
3,685
|
25.78
|
US$95,000
|
|
|
2024-03-12 |
2024-03-08 |
PlS
Planned sale
|
SVP & Chief Accounting Officer
Officer
|
3,685
-9.7%
25.63
US$94,447
|
3,685
-9.7%
|
25.63
|
US$94,447
|
|
|
2024-03-01 |
2024-03-01 |
PrS
Proposed sale
|
Officer
Officer
|
232,267
25.02
US$5,811,277
|
232,267
|
25.02
|
US$5,811,277
|
|
|
2024-03-01 |
2024-02-29 |
S
Sale
|
EVP, AMEA
Officer
|
13,074
-13.5%
24.53
US$320,705
|
13,074
-13.5%
|
24.53
|
US$320,705
|
|
|
2024-03-01 |
2024-02-29 |
S
Sale
|
EVP Sales, Customer Excellence
Officer
|
4,910
-4.9%
24.52
US$120,393
|
4,910
-4.9%
|
24.52
|
US$120,393
|
|
|
2024-02-29 |
2024-02-29 |
PrS
Proposed sale
|
Officer
Officer
|
13,074
24.53
US$320,755
|
13,074
|
24.53
|
US$320,755
|
|
|
2024-02-29 |
2024-02-29 |
PrS
Proposed sale
|
Officer
Officer
|
4,910
24.52
US$120,417
|
4,910
|
24.52
|
US$120,417
|
|
|
2024-02-27 |
2024-02-27 |
PrS
Proposed sale
|
Officer
Officer
|
6,203
24.50
US$151,944
|
6,203
|
24.50
|
US$151,944
|
|
|
2024-02-27 |
2024-02-27 |
S
Sale
|
EVP Sales, Customer Excellence
Officer
|
6,203
-5.8%
24.49
US$151,911
|
6,203
-5.8%
|
24.49
|
US$151,911
|
|
|
2023-10-26 |
2023-10-26 |
PrS
Proposed sale
|
Former Officer
Officer
|
41,059
19.42
US$797,200
|
41,059
|
19.42
|
US$797,200
|
|
|
2023-10-16 |
2023-10-16 |
PrS
Proposed sale
|
Former officer
Officer
|
37,816
21.61
US$817,200
|
37,816
|
21.61
|
US$817,200
|
|
|
2023-10-12 |
2023-10-12 |
PrS
Proposed sale
|
Former officer
Officer
|
82,117
21.24
US$1,744,466
|
82,117
|
21.24
|
US$1,744,466
|
|
|
2023-09-20 |
2023-09-20 |
PrS
Proposed sale
|
Former officer
Officer
|
75,000
22.04
US$1,652,800
|
75,000
|
22.04
|
US$1,652,800
|
|
|
2023-09-12 |
2023-09-12 |
PrS
Proposed sale
|
Former officer
Officer
|
110,000
21.36
US$2,349,630
|
110,000
|
21.36
|
US$2,349,630
|
|
|
2023-09-07 |
2023-09-07 |
PrS
Proposed sale
|
Officer
Officer
|
7,577
20.64
US$156,421
|
7,577
|
20.64
|
US$156,421
|
|
|
2023-09-07 |
2023-09-07 |
S
Sale
|
SVP & Chief Accounting Officer
Officer
|
7,577
-21.2%
20.64
US$156,389
|
7,577
-21.2%
|
20.64
|
US$156,389
|
|
|
2023-08-28 |
2023-08-25 |
S
Sale
|
EVP, Americas and Europe
Officer
|
25,000
-13.5%
21.47
US$536,750
|
25,000
-13.5%
|
21.47
|
US$536,750
|
|
|
2023-08-25 |
2023-08-24 |
PrS
Proposed sale
|
Officer
Officer
|
25,000
21.48
US$537,000
|
25,000
|
21.48
|
US$537,000
|
|
|
2023-04-13 |
2023-04-11 |
S
Sale
|
EVP, AMEA
Officer
|
1,498
-1.5%
21.18
US$31,728
|
1,498
-1.5%
|
21.18
|
US$31,728
|
|
|
2023-04-11 |
2023-04-11 |
PrS
Proposed sale
|
Officer
Officer
|
1,498
21.18
US$31,727
|
1,498
|
21.18
|
US$31,727
|
|
|
2023-03-06 |
2023-03-03 |
PlS
Planned sale
|
EVP, Biopharma Production
Officer
|
3,914
-3.5%
25.00
US$97,850
|
3,914
-3.5%
|
25.00
|
US$97,850
|
|
|
2023-03-01 |
2023-02-28 |
PlS
Planned sale
|
EVP, AMEA
Officer
|
2,324
-2.3%
24.32
US$56,520
|
2,324
-2.3%
|
24.32
|
US$56,520
|
|
|
2023-03-01 |
2023-02-27 |
PlS
Planned sale
|
EVP, Biopharma Production
Officer
|
3,059
-2.6%
25.00
US$76,475
|
3,059
-2.6%
|
25.00
|
US$76,475
|
|
|
2023-02-27 |
2023-02-23 |
PlS
Planned sale
|
EVP, AMEA
Officer
|
3,078
-3.2%
24.24
US$74,611
|
3,078
-3.2%
|
24.24
|
US$74,611
|
|
|
2023-02-22 |
2023-02-22 |
PlS
Planned sale
|
EVP, AMEA
Officer
|
19,160
-16.5%
24.12
US$462,139
|
19,160
-16.5%
|
24.12
|
US$462,139
|
|
|
2023-02-02 |
2023-02-02 |
PlS
Planned sale
|
EVP, Biopharma Production
Officer
|
11,339
-10.0%
25.06
US$284,155
|
11,339
-10.0%
|
25.06
|
US$284,155
|
|
|
2022-11-17 |
2022-11-16 |
B
Purchase
|
EVP & CFO
Officer
|
12,500
+54.0%
20.71
US$258,850
|
12,500
+54.0%
|
20.71
|
US$258,850
|
|
|
2022-11-17 |
2022-11-16 |
B
Purchase
|
CEO
Executive Director
|
15,000
+3.6%
20.95
US$314,250
|
15,000
+3.6%
|
20.95
|
US$314,250
|
|
|
2022-05-23 |
2022-05-23 |
S
Sale
|
EVP, Americas & Europe
Officer
|
39,000
-23.5%
31.61
US$1,232,790
|
39,000
-23.5%
|
31.61
|
US$1,232,790
|
|
|
2022-05-23 |
2022-05-20 |
PlS
Planned sale
|
EVP, Biopharma Production
Officer
|
19,603
-16.8%
31.27
US$612,986
|
19,603
-16.8%
|
31.27
|
US$612,986
|
|
|
2022-03-02 |
2022-03-01 |
PlS
Planned sale
|
EVP, Biopharma Production
Officer
|
2,027
-1.5%
34.47
US$69,871
|
2,027
-1.5%
|
34.47
|
US$69,871
|
|
|
2022-02-25 |
2022-02-23 |
PlS
Planned sale
|
EVP, Biopharma Production
Officer
|
3,059
-2.4%
33.79
US$103,364
|
3,059
-2.4%
|
33.79
|
US$103,364
|
|
|
2022-01-05 |
2022-01-05 |
PlS
Planned sale
|
EVP, Biopharma Production
Officer
|
11,551
-8.1%
38.65
US$446,446
|
11,551
-8.1%
|
38.65
|
US$446,446
|
|
|
2022-01-05 |
2022-01-03 |
PlS
Planned sale
|
EVP, Biopharma Production
Officer
|
59,418
-29.4%
40.77
US$2,422,472
|
59,418
-29.4%
|
40.77
|
US$2,422,472
|
|
|
2021-12-23 |
2021-12-22 |
PlS
Planned sale
|
EVP, AMEA
Officer
|
28,125
-20.3%
41.53
US$1,168,031
|
28,125
-20.3%
|
41.53
|
US$1,168,031
|
|
|
2021-12-23 |
2021-12-21 |
PlS
Planned sale
|
EVP, AMEA
Officer
|
38,309
-25.7%
41.00
US$1,570,669
|
38,309
-25.7%
|
41.00
|
US$1,570,669
|
|
|
2021-12-10 |
2021-12-09 |
PlS
Planned sale
|
EVP, AMEA
Officer
|
7,859
-6.6%
40.24
US$316,246
|
7,859
-6.6%
|
40.24
|
US$316,246
|
|
|
2021-12-10 |
2021-12-08 |
PlS
Planned sale
|
EVP, AMEA
Officer
|
5,828
-5.0%
40.00
US$233,120
|
5,828
-5.0%
|
40.00
|
US$233,120
|
|
|
2021-12-03 |
2021-12-01 |
PlS
Planned sale
|
Non-Executive Director
|
100,000
-10.2%
39.30
US$3,930,000
|
100,000
-10.2%
|
39.30
|
US$3,930,000
|
|
|
2021-11-15 |
2021-11-12 |
S
Sale
|
EVP, Europe
Officer
|
80,000
-34.1%
38.25
US$3,060,000
|
80,000
-34.1%
|
38.25
|
US$3,060,000
|
|